A vaccine for COVID-19, developed by researchers at the University of Oxford, will begin trials on humans this Thursday, announced the UK's Health Secretary Matt Hancock.
Speaking during a daily press briefing on the coronavirus outbreak, Hancock reiterated the government's support for two vaccination projects in the UK, one developed by the researchers at Oxford and another at Imperial College London.
